1.
Das M, Zhu C, Kuchroo VK. Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev. 2017;276(1):97-111. doi:10.1111/imr.12520.
1.
Goods BA, Hernandez AL, Lowther DE, et al. Functional differences between PD-1+ and PD-1- CD4+ effector T cells in healthy donors and patients with glioblastoma multiforme. PLoS One. 2017;12(9):e0181538. doi:10.1371/journal.pone.0181538.
1.
Wang C, Edilova MI, Wagar LE, et al. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. J Immunol. 2018;200(2):558-564. doi:10.4049/jimmunol.1601254.
1.
Haining N. Thinking inside the box: how T cell inhibitory receptors signal. Nat Med. 2012;18(9):1338-9. doi:10.1038/nm.2921.
1.
Koyama S, Akbay EA, Li YY, et al. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nat Commun. 2016;7:10501. doi:10.1038/ncomms10501.